US Stock MarketDetailed Quotes

IPSC Century Therapeutics

Watchlist
  • 0.909
  • +0.004+0.45%
Close Jan 17 16:00 ET
  • 0.909
  • 0.0000.00%
Post 16:02 ET
77.32MMarket Cap-0.50P/E (TTM)

Century Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
434.46%791K
678.79%771K
-50.29%855K
-57.01%2.24M
-48.56%268K
-93.35%148K
-92.91%99K
62.57%1.72M
5.2M
521K
Operating revenue
434.46%791K
678.79%771K
-50.29%855K
-57.01%2.24M
-48.56%268K
-93.35%148K
-92.91%99K
62.57%1.72M
--5.2M
--521K
Cost of revenue
Gross profit
Operating expense
11.98%35.58M
14.76%35.53M
-4.84%32.16M
-1.25%127.42M
-8.70%30.89M
-6.44%31.77M
-5.47%30.96M
18.62%33.8M
35.99%129.03M
20.93%33.83M
Selling and administrative expenses
-7.06%8.35M
0.94%8.31M
-1.79%8.74M
8.94%34.71M
4.21%8.59M
11.43%8.99M
-0.29%8.23M
21.98%8.9M
65.62%31.86M
33.43%8.24M
-General and administrative expense
-7.06%8.35M
0.94%8.31M
-1.79%8.74M
8.94%34.71M
4.21%8.59M
11.43%8.99M
-0.29%8.23M
21.98%8.9M
65.62%31.86M
33.43%8.24M
Research and development costs
19.48%27.23M
19.77%27.22M
-5.94%23.42M
-4.59%92.71M
-12.86%22.3M
-12.01%22.79M
-7.21%22.73M
17.47%24.9M
28.45%97.17M
17.38%25.59M
Operating profit
-10.00%-34.79M
-12.63%-34.76M
2.41%-31.31M
-1.09%-125.18M
8.07%-30.62M
0.35%-31.63M
1.58%-30.86M
-16.93%-32.08M
-30.51%-123.83M
-19.06%-33.31M
Net non-operating interest income expense
-5.19%3.31M
22.59%3.58M
45.88%3.24M
305.92%12.14M
114.42%3.51M
235.84%3.49M
677.13%2.92M
3,737.70%2.22M
334.51%2.99M
609.97%1.64M
Non-operating interest income
-5.19%3.31M
17.14%3.58M
23.41%3.24M
186.81%12.68M
71.22%3.51M
147.06%3.49M
333.14%3.06M
936.76%2.62M
--4.42M
--2.05M
Non-operating interest expense
--0
--0
--0
-55.00%540K
--0
--0
-46.46%136K
46.22%348K
23.84%1.2M
69.26%413K
Total other finance cost
----
----
----
----
----
----
----
-26.32%56K
-24.84%230K
--0
Other net income (expense)
106.27%250K
99.73%-12K
105.67%11K
-117.48%-21.75M
-69,363.16%-13.16M
-16,516.67%-3.99M
-88,220.00%-4.41M
98.06%-194K
-2,752.52%-10M
-86.71%19K
Special income (charges)
--0
--0
----
-113.65%-21.37M
---13.15M
---4M
---4.22M
----
---10M
--0
-Less:Impairment of capital assets
--0
--0
----
--16.37M
--12.15M
--0
--4.22M
----
--0
--0
-Less:Other special charges
----
----
----
-50.00%5M
--1M
--4M
----
----
--10M
--0
Other non- operating income (expenses)
1,983.33%250K
93.55%-12K
105.67%11K
---383K
---15K
150.00%12K
-3,820.00%-186K
---194K
----
----
Income before tax
2.78%-31.23M
3.57%-31.19M
6.64%-28.06M
-3.02%-134.79M
-27.23%-40.27M
-4.57%-32.13M
-4.43%-32.34M
19.84%-30.06M
-36.60%-130.84M
-12.43%-31.65M
Income tax
-101.35%-8K
-97.68%22K
-99.92%1K
1,967.03%1.88M
-2,815.63%-869K
2,268.00%592K
5,177.78%950K
7,450.00%1.21M
111.63%91K
32K
Net income
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-36.64%-130.93M
-12.37%-31.68M
Net income continuous Operations
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-36.64%-130.93M
-12.37%-31.68M
Minority interest income
Net income attributable to the parent company
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-36.64%-130.93M
-12.37%-31.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-36.64%-130.93M
-12.37%-31.68M
Basic earnings per share
32.73%-0.37
32.14%-0.38
15.09%-0.45
-1.32%-2.3
-18.18%-0.65
-3.77%-0.55
-3.70%-0.56
19.70%-0.53
23.31%-2.27
-7.30%-0.55
Diluted earnings per share
32.73%-0.37
32.14%-0.38
15.09%-0.45
-1.32%-2.3
-18.18%-0.65
-3.77%-0.55
-3.70%-0.56
19.70%-0.53
23.31%-2.27
-7.30%-0.55
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 434.46%791K 678.79%771K -50.29%855K -57.01%2.24M -48.56%268K -93.35%148K -92.91%99K 62.57%1.72M 5.2M 521K
Operating revenue 434.46%791K 678.79%771K -50.29%855K -57.01%2.24M -48.56%268K -93.35%148K -92.91%99K 62.57%1.72M --5.2M --521K
Cost of revenue
Gross profit
Operating expense 11.98%35.58M 14.76%35.53M -4.84%32.16M -1.25%127.42M -8.70%30.89M -6.44%31.77M -5.47%30.96M 18.62%33.8M 35.99%129.03M 20.93%33.83M
Selling and administrative expenses -7.06%8.35M 0.94%8.31M -1.79%8.74M 8.94%34.71M 4.21%8.59M 11.43%8.99M -0.29%8.23M 21.98%8.9M 65.62%31.86M 33.43%8.24M
-General and administrative expense -7.06%8.35M 0.94%8.31M -1.79%8.74M 8.94%34.71M 4.21%8.59M 11.43%8.99M -0.29%8.23M 21.98%8.9M 65.62%31.86M 33.43%8.24M
Research and development costs 19.48%27.23M 19.77%27.22M -5.94%23.42M -4.59%92.71M -12.86%22.3M -12.01%22.79M -7.21%22.73M 17.47%24.9M 28.45%97.17M 17.38%25.59M
Operating profit -10.00%-34.79M -12.63%-34.76M 2.41%-31.31M -1.09%-125.18M 8.07%-30.62M 0.35%-31.63M 1.58%-30.86M -16.93%-32.08M -30.51%-123.83M -19.06%-33.31M
Net non-operating interest income expense -5.19%3.31M 22.59%3.58M 45.88%3.24M 305.92%12.14M 114.42%3.51M 235.84%3.49M 677.13%2.92M 3,737.70%2.22M 334.51%2.99M 609.97%1.64M
Non-operating interest income -5.19%3.31M 17.14%3.58M 23.41%3.24M 186.81%12.68M 71.22%3.51M 147.06%3.49M 333.14%3.06M 936.76%2.62M --4.42M --2.05M
Non-operating interest expense --0 --0 --0 -55.00%540K --0 --0 -46.46%136K 46.22%348K 23.84%1.2M 69.26%413K
Total other finance cost ---- ---- ---- ---- ---- ---- ---- -26.32%56K -24.84%230K --0
Other net income (expense) 106.27%250K 99.73%-12K 105.67%11K -117.48%-21.75M -69,363.16%-13.16M -16,516.67%-3.99M -88,220.00%-4.41M 98.06%-194K -2,752.52%-10M -86.71%19K
Special income (charges) --0 --0 ---- -113.65%-21.37M ---13.15M ---4M ---4.22M ---- ---10M --0
-Less:Impairment of capital assets --0 --0 ---- --16.37M --12.15M --0 --4.22M ---- --0 --0
-Less:Other special charges ---- ---- ---- -50.00%5M --1M --4M ---- ---- --10M --0
Other non- operating income (expenses) 1,983.33%250K 93.55%-12K 105.67%11K ---383K ---15K 150.00%12K -3,820.00%-186K ---194K ---- ----
Income before tax 2.78%-31.23M 3.57%-31.19M 6.64%-28.06M -3.02%-134.79M -27.23%-40.27M -4.57%-32.13M -4.43%-32.34M 19.84%-30.06M -36.60%-130.84M -12.43%-31.65M
Income tax -101.35%-8K -97.68%22K -99.92%1K 1,967.03%1.88M -2,815.63%-869K 2,268.00%592K 5,177.78%950K 7,450.00%1.21M 111.63%91K 32K
Net income 4.57%-31.23M 6.26%-31.21M 10.24%-28.06M -4.38%-136.67M -24.35%-39.4M -6.41%-32.72M -7.43%-33.29M 16.66%-31.26M -36.64%-130.93M -12.37%-31.68M
Net income continuous Operations 4.57%-31.23M 6.26%-31.21M 10.24%-28.06M -4.38%-136.67M -24.35%-39.4M -6.41%-32.72M -7.43%-33.29M 16.66%-31.26M -36.64%-130.93M -12.37%-31.68M
Minority interest income
Net income attributable to the parent company 4.57%-31.23M 6.26%-31.21M 10.24%-28.06M -4.38%-136.67M -24.35%-39.4M -6.41%-32.72M -7.43%-33.29M 16.66%-31.26M -36.64%-130.93M -12.37%-31.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.57%-31.23M 6.26%-31.21M 10.24%-28.06M -4.38%-136.67M -24.35%-39.4M -6.41%-32.72M -7.43%-33.29M 16.66%-31.26M -36.64%-130.93M -12.37%-31.68M
Basic earnings per share 32.73%-0.37 32.14%-0.38 15.09%-0.45 -1.32%-2.3 -18.18%-0.65 -3.77%-0.55 -3.70%-0.56 19.70%-0.53 23.31%-2.27 -7.30%-0.55
Diluted earnings per share 32.73%-0.37 32.14%-0.38 15.09%-0.45 -1.32%-2.3 -18.18%-0.65 -3.77%-0.55 -3.70%-0.56 19.70%-0.53 23.31%-2.27 -7.30%-0.55
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- -- --
Heat List
US
Overall
Symbol
Price
% Chg

No Data